Suppr超能文献

黄连解毒汤通过调节微生物组网络药理学和分子对接分析治疗阿尔茨海默病的分子机制。

Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome network pharmacology and molecular docking analysis.

机构信息

Sichuan Key Laboratory of Noncoding RNA and Drugs, School of Basic Medical Sciences, Chengdu Medical College, Chengdu, China.

Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.

出版信息

Front Cell Infect Microbiol. 2023 Mar 16;13:1140945. doi: 10.3389/fcimb.2023.1140945. eCollection 2023.

Abstract

BACKGROUND

Huanglian Jiedu decoction (HLJDD) is a famous traditional Chinese medicine prescription, which is widely used in the treatment of Alzheimer's disease (AD). However, the interaction between bioactive substances in HLJDD and AD-related targets has not been well elucidated.

AIM

A network pharmacology-based approach combined with molecular docking was performed to determine the bioactives, key targets, and potential pharmacological mechanism of HLJDD against AD, through the regulation of microbial flora.

MATERIALS AND METHODS

Bioactives and potential targets of HLJDD, as well as AD-related targets, were retrieved from Traditional Chinese Medicine Systems Pharmacology Analysis Database (TCMSP). Key bioactive components, potential targets, and signaling pathways were obtained through bioinformatics analysis, including protein-protein interaction (PPI), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Subsequently, molecular docking was performed to predict the binding of active compounds with core targets.

RESULTS

102 bioactive ingredients of HLJDD and 76 HLJDD-AD-related targets were screened. Bioinformatics analysis revealed that kaempferol, wogonin, beta-sitosterol, baicalein, acacetin, isocorypalmine, (S)-canadine, (R)-canadine may be potential candidate agents. AKT1, TNF, TP53, VEGFA, FOS, PTGS2, MMP9 and CASP3 could become potential therapeutic targets. 15 important signaling pathways including the cancer pathway, VEGF signaling pathway, and NF-κB signaling pathway might play an important role in HLJDD against AD. Moreover, molecular docking analysis suggested that kaempferol, wogonin, beta-sitosterol, baicalein, acacetin, isocorypalmine, (S)-canadine, and (R)-canadine combined well with AKT1, TNF, TP53, VEGFA, FOS, PTGS2, MMP9, CASP3, respectively.

CONCLUSION

Our results comprehensively illustrated the bioactives, potential targets, and possible molecular mechanisms of HLJDD against AD. HLJDD may regulate the microbiota flora homeostasis to treat AD through multiple targets and multiple pathways. It also provided a promising strategy for the use of traditional Chinese medicine in treating human diseases.

摘要

背景

黄连解毒汤(HLJDD)是一种著名的中药方剂,广泛用于治疗阿尔茨海默病(AD)。然而,HLJDD 中的生物活性物质与 AD 相关靶点之间的相互作用尚未得到很好的阐明。

目的

采用网络药理学方法结合分子对接技术,确定 HLJDD 通过调节微生物群落治疗 AD 的生物活性物质、关键靶点和潜在的药理机制。

材料和方法

从中药系统药理学分析数据库(TCMSP)中检索 HLJDD 的生物活性物质和潜在靶点,以及 AD 相关靶点。通过生物信息学分析获得关键生物活性成分、潜在靶点和信号通路,包括蛋白质-蛋白质相互作用(PPI)、基因本体论(GO)和京都基因与基因组百科全书(KEGG)分析。然后,进行分子对接以预测活性化合物与核心靶点的结合。

结果

筛选出 102 种 HLJDD 的生物活性成分和 76 种 HLJDD-AD 相关靶点。生物信息学分析表明,山奈酚、白杨素、β-谷甾醇、黄芩素、木犀草素、异苦参碱、(S)-加拿大麻碱和(R)-加拿大麻碱可能是潜在的候选药物。AKT1、TNF、TP53、VEGFA、FOS、PTGS2、MMP9 和 CASP3 可能成为潜在的治疗靶点。15 个重要的信号通路,包括癌症途径、VEGF 信号通路和 NF-κB 信号通路,可能在 HLJDD 治疗 AD 中发挥重要作用。此外,分子对接分析表明,山奈酚、白杨素、β-谷甾醇、黄芩素、木犀草素、异苦参碱、(S)-加拿大麻碱和(R)-加拿大麻碱与 AKT1、TNF、TP53、VEGFA、FOS、PTGS2、MMP9 和 CASP3 结合良好。

结论

本研究全面阐述了 HLJDD 治疗 AD 的生物活性物质、潜在靶点和可能的分子机制。HLJDD 可能通过多种靶点和多种途径调节微生物群落的内稳态来治疗 AD。这也为中药治疗人类疾病提供了一种有前途的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e90/10060893/8170264279f5/fcimb-13-1140945-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验